دورية أكاديمية
Efficacy and safety of glucagon-like peptide-1 receptor agonists on prediabetes: a systematic review and meta-analysis of randomized controlled trials.
| العنوان: | Efficacy and safety of glucagon-like peptide-1 receptor agonists on prediabetes: a systematic review and meta-analysis of randomized controlled trials. |
|---|---|
| المؤلفون: | Salamah, Hazem Mohamed, Marey, Ahmed, Abugdida, Mohamed, Abualkhair, Khaled Alsayed, Elshenawy, Salem, Elhassan, Wael Atif Fadl, Naguib, Mostafa Mahmoud, Malnev, Dmitrii, Durrani, Jamrose, Bailey, Ronelle, Tsyunchyk, Anastasiia, Ibrahim, Lena, Zavgorodneva, Zhanna, Sherazi, Andleeb |
| المصدر: | Diabetol Metab Syndr ; ISSN:1758-5996 ; Volume:16 ; Issue:1 |
| بيانات النشر: | BioMed Central |
| سنة النشر: | 2024 |
| المجموعة: | PubMed Central (PMC) |
| مصطلحات موضوعية: | Diabetes, Impaired, Lifestyle, Liraglutide, Normoglycemia, Prediabetes, Regression, Reversion, Tolerance |
| الوصف: | Prediabetes is a condition preceding the development of diabetes and is associated with an increased risk of a number of complications. The primary mode of management is thought to be lifestyle modification. Pharmacological therapy, such as glucagon-like peptide-1 receptor agonists (GLP-1RAs), were not well addressed in the literature and were only evaluated in trials as secondary and exploratory outcomes with a limited sample size. Here, GLP-1RAs are evaluated as a comprehensive therapy approach for patients with prediabetes. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://doi.org/10.1186/s13098-024-01371-3Test; https://pubmed.ncbi.nlm.nih.gov/38877565Test |
| DOI: | 10.1186/s13098-024-01371-3 |
| الإتاحة: | https://doi.org/10.1186/s13098-024-01371-3Test https://pubmed.ncbi.nlm.nih.gov/38877565Test |
| حقوق: | © 2024. The Author(s). |
| رقم الانضمام: | edsbas.1F2ED3A6 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1186/s13098-024-01371-3 |
|---|